Published by Oliver Haill on 26th February 2018
(ShareCast News) - Shares in Hemogenyx Pharmaceuticals rocketed over 120% after details were released of a patent application for a "new type of humanised mouse" that can be used to show how antibodies developed by the biotech company can treat leukaemia.
URL: http://www.digitallook.com/dl/news/story/27113893/...